Analysts think PAVM stock price could increase by 1664%
May 10, 2025, 11:25 AM
-5.71%
What does PAVM do
PAVmed, a New York-based medical device company, specializes in medical technologies and employs 107 staff. Its subsidiaries include Lucid Diagnostics, offering cancer detection products, and Veris Health, focused on personalized cancer care.
4 analysts think PAVM stock price will increase by 1664.06%. The current median analyst target is $11.98 compared to a current stock price of $0.68. The lowest analysts target is $4.04 and the highest analyst target is $20.48.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
